MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Incompatible

Zyprexa 20mg Velotabs (Neon Healthcare Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 20mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 20mg Velotabs (Eli Lilly and Company Ltd).

Incompatible

Zyprexa 20mg Velotabs (Sigma Pharmaceuticals Plc)

Explore other Olanzapine formulations Explore other Olanzapine 20mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 20mg Velotabs (Eli Lilly and Company Ltd).

Use with caution

Zyprexa 5mg tablets (CST Pharma Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 5mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Use with caution

Zyprexa 5mg tablets (Necessity Supplies Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 5mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Use with caution

Zyprexa 5mg tablets (Neon Healthcare Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 5mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Use with caution

Zyprexa 5mg tablets (Sigma Pharmaceuticals Plc)

Explore other Olanzapine formulations Explore other Olanzapine 5mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Incompatible

Zyprexa 5mg Velotabs (Abacus Medicine Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 5mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatiblity information derived from Zyprexa 5mg Velotabs (Eli Lily and Company Ltd).

Incompatible

Zyprexa 5mg Velotabs (CST Pharma Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 5mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatiblity information derived from Zyprexa 5mg Velotabs (Eli Lily and Company Ltd).

Incompatible

Zyprexa 5mg Velotabs (Neon Healthcare Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 5mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatiblity information derived from Zyprexa 5mg Velotabs (Eli Lily and Company Ltd).

Incompatible

Zyprexa 5mg Velotabs (Sigma Pharmaceuticals Plc)

Explore other Olanzapine formulations Explore other Olanzapine 5mg oral lyophilisates sugar free suppliers

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatiblity information derived from Zyprexa 5mg Velotabs (Eli Lily and Company Ltd).

Use with caution

Zyprexa 7.5mg tablets (CST Pharma Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 7.5mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Use with caution

Zyprexa 7.5mg tablets (Neon Healthcare Ltd)

Explore other Olanzapine formulations Explore other Olanzapine 7.5mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Use with caution

Zyprexa 7.5mg tablets (Sigma Pharmaceuticals Plc)

Explore other Olanzapine formulations Explore other Olanzapine 7.5mg tablets suppliers

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

No Stability Information

Zytiga 500mg tablets (Janssen-Cilag Ltd)

Explore other Abiraterone formulations Explore other Abiraterone 500mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Compatible

Zyvox 600mg tablets (Pfizer Ltd)

Explore other Linezolid formulations Explore other Linezolid 600mg tablets suppliers

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zyvox 600mg tablets (Pfizer Ltd).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.